AMPH FY 2015 Earnings — Amphastar Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

AMPHAmphastar Pharmaceuticals, Inc.

$860M

FY 2015 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$252M+19.5% YoY

Gross Profit

$77M30.8% margin

Operating Income

-$7M-2.7% margin

Net Income

-$3M-1.1% margin

EPS (Diluted)

$-0.06

Cash Flow

Operating Cash Flow

$11M

Free Cash Flow

-$5M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$390M

Total Liabilities

$95M

Stockholders' Equity

$296M

Cash & Equivalents

$66M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$252M	$210M	+19.5%
Gross Profit	$77M	$51M	+50.9%
Operating Income	-$7M	-$18M	+61.6%
Net Income	-$3M	-$11M	+74.0%